{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:13:14Z","timestamp":1789603994897,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cgh.2019.05.027","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T14:11:30Z","timestamp":1558534290000},"page":"628-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Guillaume","family":"Bouguen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Viennot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Cholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nachury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathurin","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Reimund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Desfourneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Boureille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Siproudhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl A","key":"10.1016\/j.cgh.2019.05.027_bib1","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.027_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2010.06.070","article-title":"Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort","volume":"139","author":"Thia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.027_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.027_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.49.6.777","article-title":"Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease","volume":"49","author":"Louis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.027_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cgh.2012.07.006","article-title":"Strategies for the care of adults hospitalized for active ulcerative colitis","volume":"10","author":"Pola","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.05.027_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2019.05.027_bib7","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.05.027_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1572-0241.2001.03612.x","article-title":"Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients","volume":"96","author":"Ricart","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.027_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ajg.2014.183","article-title":"Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID","volume":"109","author":"Amiot","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.027_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.suc.2007.03.011","article-title":"Operative management of small bowel Crohn's disease","volume":"87","author":"Gardiner","year":"2007","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.cgh.2019.05.027_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00054725-200401000-00006","article-title":"Infliximab: lack of efficacy on perforating complications in Crohn's disease","volume":"10","author":"Miehsler","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.05.027_bib12","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.2002.05918.x","article-title":"Combining infliximab with 6-mercaptopurine\/azathioprine for fistula therapy in Crohn's disease","volume":"97","author":"Ochsenkuhn","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.027_bib13","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/MIB.0000000000001276","article-title":"Real-world experience of anti-tumor necrosis factor therapy for internal fistulas in Crohn's disease: a retrospective multicenter cohort study","volume":"23","author":"Kobayashi","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.05.027_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ecco-jcc\/jjw016","article-title":"Outcomes of medical and surgical therapy for entero-urinary fistulas in Crohn's disease","volume":"10","author":"Taxonera","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2019.05.027_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s004280000226","article-title":"Significant association of strictures and internal fistula formation in Crohn's disease","volume":"437","author":"Oberhuber","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cgh.2019.05.027_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/gutjnl-2016-312581","article-title":"Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study","volume":"67","author":"Bouhnik","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.027_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10350-004-6296-8","article-title":"Remicade does not abolish the need for surgery in fistulizing Crohn's disease","volume":"45","author":"Poritz","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2019.05.027_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.05.027_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab","volume":"11","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.05.027_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.crohns.2013.04.006","article-title":"Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)","volume":"8","author":"Magro","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2019.05.027_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-alpha therapy in inflammatory bowel disease","volume":"39","author":"Williams","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2019.05.027_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.05.027_bib23","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.3748\/wjg.v20.i33.11486","article-title":"Small bowel adenocarcinoma and Crohn's disease: any further ahead than 50 years ago?","volume":"20","author":"Cahill","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.027_bib24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/gut.35.7.950","article-title":"Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention","volume":"35","author":"Choi","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.027_bib25","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.35.11.1590","article-title":"Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis","volume":"35","author":"Gillen","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.05.027_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(00)03612-6","article-title":"Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study","volume":"357","author":"Askling","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2019.05.027_bib27","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3748\/wjg.14.2662","article-title":"Colorectal cancer and dysplasia in inflammatory bowel disease","volume":"14","author":"Zisman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.05.027_bib28","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.cgh.2015.04.185","article-title":"Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures","volume":"13","author":"Fumery","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.05.027_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651930549X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651930549X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:29:41Z","timestamp":1761542981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651930549X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S154235651930549X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.05.027","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}